CLINICAL_TRIALS trial_result · 2016-05-24

Clinical Trial Update: Atacicept in Multiple Sclerosis Extension Study, Phase II [Phase 2]

Phase II extension study of atacicept in relapsing multiple sclerosis was terminated. Results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: EMD Serono | Conditions: Relapsing Multiple Sclerosis | Phase 2 | Status: TERMINATED | Results posted: 2016-05-24